12/222025

Enoxaparin Sodium: Strengthening Anticoagulant Supply Chain Resilience with Jiulong’s Quality Assurance

Thromboembolicdiseases,includingdeepveinthrombosisandpulmonaryembolism,havebecomeaglobalpublichealthburden,affectingmillionsofpatientsannually.Asagold-standardlowmolecularweightheparin,EnoxaparinSodiu

Click to view

12/192025

Heparin Sodium Price in 2025: Key Drivers and Strategic Procurement Insights

TheglobalpharmaceuticalmarkethaswitnessedsignificantvolatilityinHeparinSodiumpricesince2024,withanotablereboundof27%inthefirstquarterof2025alone,followingaperiodofbottomingout.Forpharmaceuticaldistrib

Click to view

12/182025

Enoxaparin Sodium: Safety and Efficacy in Anticoagulation for Special Populations

Anticoagulanttherapyrequiresprecisebalancingofefficacyandsafety,especiallyforspecialpopulationssuchaspregnantwomen,elderlypatientsundergoingorthopedicsurgery,andbreastfeedingmothers.Thesegroupsfaceuni

Click to view

12/172025

Heparins Manufacturer: Key Criteria for Choosing Amid Global Supply Chain Shifts and Bioengineering Innovations

Theglobalheparinmarketisundergoingacriticaltransformation,drivenbysupplychainreconfiguration,risingdemandfromagingpopulations,andbreakthroughsinbioengineeringtechnologies.Ashealthcareprovidersandpharm

Click to view

12/162025

Dalteparin Sodium: A Game-Changer in VTE Management for Cancer Patients

Venousthromboembolism(VTE),encompassingdeepveinthrombosis(DVT)andpulmonaryembolism(PE),isalife-threateningcomplicationforcancerpatients,withtheirriskofdevelopingVTEbeing4to7timeshigherthanthatofthegen

Click to view

News and information